KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Guardant Health (GH) Net Income: 2017-2025

Historic Net Income for Guardant Health (GH) over the last 8 years, with Sep 2025 value amounting to -$92.7 million.

  • Guardant Health's Net Income rose 13.95% to -$92.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$398.8 million, marking a year-over-year increase of 22.17%. This contributed to the annual value of -$436.4 million for FY2024, which is 8.98% up from last year.
  • Guardant Health's Net Income amounted to -$92.7 million in Q3 2025, which was up 7.18% from -$99.9 million recorded in Q2 2025.
  • In the past 5 years, Guardant Health's Net Income registered a high of -$72.3 million during Q4 2021, and its lowest value of -$229.4 million during Q2 2022.
  • In the last 3 years, Guardant Health's Net Income had a median value of -$102.6 million in 2024 and averaged -$109.4 million.
  • Per our database at Business Quant, Guardant Health's Net Income plummeted by 237.30% in 2021 and then surged by 68.28% in 2023.
  • Over the past 5 years, Guardant Health's Net Income (Quarterly) stood at -$72.3 million in 2021, then slumped by 93.52% to -$139.9 million in 2022, then plummeted by 33.67% to -$187.0 million in 2023, then spiked by 40.65% to -$111.0 million in 2024, then grew by 13.95% to -$92.7 million in 2025.
  • Its last three reported values are -$92.7 million in Q3 2025, -$99.9 million for Q2 2025, and -$95.2 million during Q1 2025.